The Evolving Approach to Breast Cancer: Moving toward De-Escalating Treatment and Personalized Medicine

被引：2
|
作者：
Khoury, Thaer [1 ]
机构：
[1] Roswell Pk Canc Inst, Dept Pathol, Elm & Carlton St, Buffalo, NY 14263 USA
来源：
CANCERS | 2023年 / 15卷 / 13期
关键词：
CONSERVING THERAPY; RADIOTHERAPY; MARGINS;
D O I：
10.3390/cancers15133502
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] De-escalating systemic chemotherapy might be considered for pure triple negative apocrine breast cancer patients
    Altundag, Kadri
    JOURNAL OF BUON, 2019, 24 (02): : 864 - 864
  • [42] Rituximab Therapy in Neuromyelitis Optica Moving Toward a Personalized Medicine Approach
    Tobin, W. Oliver
    Pittock, Sean J.
    JAMA NEUROLOGY, 2015, 72 (09) : 974 - 977
  • [43] Personalized medicine for breast cancer: moving forward and going back
    Ross, Jeffrey S.
    Symmans, W. Fraser
    Pusztai, Lajos
    Hortobagyi, Gabriel N.
    PERSONALIZED MEDICINE, 2006, 3 (04) : 363 - 370
  • [44] De-escalating treatment indications for patients who achieve metabolic goals
    Garcia-Ulloa, Ana Cristina
    Jaime-Casas, Salvador
    Rosado-Lozoya, Johanna
    Serrano-Perez, NancyH.
    Hernandez-Juarez, Diana
    Cardenas-Fragoso, Jose Luis
    Briones-Garcia, Luis Eduardo
    Jimenez-Soto, Rodolfo
    Garcia-Padilla, Carlos
    Garcia-Lara, Juan
    Aguilar-Salinas, Carlos A.
    Hernandez-Jimenez, Sergio
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 208
  • [45] De-escalating therapy dilemma in small HER2 positive node negative breast cancer
    Hajjaji, Nawale
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] De-Escalating Breast or Low-Risk Ductal Carcinoma in Situ Reply
    Morrow, Monica
    Winer, Eric
    JAMA ONCOLOGY, 2020, 6 (07) : 1118 - 1118
  • [47] Moving Toward Personalized Medicine in Castration-Resistant Prostate Cancer
    Van Allen, Eliezer M.
    Pomerantz, Mark
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 483 - +
  • [48] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
    Curigliano, G.
    Burstein, H. J.
    Winer, E. P.
    Gnant, M.
    Dubsky, P.
    Loibl, S.
    Colleoni, M.
    Regan, M. M.
    Piccart-Gebhart, M.
    Senn, H. -J.
    Thurlimann, B.
    Andre, F.
    Baselga, J.
    Bergh, J.
    Bonnefoi, H.
    Brucker, S. Y.
    Cardoso, F.
    Carey, L.
    Ciruelos, E.
    Cuzick, J.
    Denkert, C.
    Di Leo, A.
    Ejlertsen, B.
    Francis, P.
    Galimberti, V.
    Garber, J.
    Gulluoglu, B.
    Goodwin, P.
    Harbeck, N.
    Hayes, D. F.
    Huang, C. -S.
    Huober, J.
    Khaled, H.
    Jassem, J.
    Jiang, Z.
    Karlsson, P.
    Morrow, M.
    Orecchia, R.
    Osborne, K. C.
    Pagani, O.
    Partridge, A. H.
    Pritchard, K.
    Ro, J.
    Rutgers, E. J. T.
    Sedlmayer, F.
    Semiglazov, V.
    Shao, Z.
    Smith, I.
    Toi, M.
    Tutt, A.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1700 - 1712
  • [49] Moving Toward Personalized Medicine in Gynecologic Cancers
    Ludwig, Michelle
    Taunk, Neil
    Chino, Junzo
    Hathout, Lara
    Leung, Eric
    Fields, Emma
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 119 (01): : 1 - 5
  • [50] De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study
    Annemiek K. E. van Hemert
    Josefien P. van Olmen
    Liesbeth J. Boersma
    John H. Maduro
    Nicola S. Russell
    Jolien Tol
    Ellen G. Engelhardt
    Emiel J. Th. Rutgers
    Marie-Jeanne T. F. D. Vrancken Peeters
    Frederieke H. van Duijnhoven
    Breast Cancer Research and Treatment, 2023, 199 : 81 - 89
12345